European Union Trademark file information

015301526

TACVANCE


April 1, 2016

Trademark Summary

The trademark application TACVANCE was filed by Teva Pharmaceutical Industries Ltd., a corporation established under the laws of the State of Israel (the "Applicant"). The application was published for oppositions on May 13, 2016, and it was registered by office on August 22, 2016 without any oppositions.

The application was filed in English (French was selected as the second language).

Change of name and address of the trademark registration was recorded on April 18, 2018. Appointment and Replacement of representative of the trademark registration was recorded on July 30, 2020. Change of name and professional address of the trademark registration was recorded on September 1, 2020. Change of name and address of the trademark registration was recorded on March 9, 2021. Change of name and address of the trademark registration was recorded on January 4, 2022.


Goods And Services

  • The mark was filed in class 5 with Immunosuppressant in patients after solid organ transplantation and in the case of acute graft rejection.